New zebrafish technique quickly finds potential treatments for multiple diseases
Skeletal muscle has proved to be very difficult to grow in patients with muscular dystrophy and other disorders that degrade and weaken muscle. Researchers at Boston Children’s Hospital‘s Stem Cell Program now report boosting muscle mass and reversing disease in a mouse model of Duchenne muscular dystrophy, using a “cocktail” of three compounds identified through a new rapid culture system. Adding the same compounds to stem cells derived from patients’ skin cells, they then successfully grew human muscle cells in a dish.
Senior investigator Leonard Zon, MD, director of the Stem Cell Program at Boston Children’s and an investigator with the Howard Hughes Medical Institute, hopes for clinical trials to begin transplanting these cells into patients with muscle loss in the next several years. In the meantime, the screening technique, described in the journal Cell (published online November 7), can also be applied to multiple disorders beyond muscular dystrophy, he says.
The drug screening technique begins with zebrafish. Zon and colleagues placed tiny zebrafish blastomeres—cells from very early stage embryos—into 384-well culture dishes, adding one test compound to each well. This allowed them to screen 2,400 compounds at once, seeking ones that boosted numbers of muscle progenitor cells in the see-through fish as they developed.
The Zon Lab’s earlier work with zebrafish led to a drug derived from prostaglandin that expands numbers of blood stem cells and is now in a Phase II clinical trial. But this time, researchers genetically modified the fish so that newly created muscle progenitor cells would show up in fluorescent green, and muscle fibers in red. This enabled the team to rapidly quantify muscle cells and fibers produced under different conditions, based on visual readouts—without having to examine each well’s contents through laborious biochemical techniques.
“Automated imagers can take a picture to assay all the 384 wells within a matter of a week, as compared with several months with our earlier technique,” says Zon, who is also a member of Boston Children’s Division of Hematology/Oncology as well as the Harvard Stem Cell Institute (HSCI).
The zebrafish tests revealed six compounds that expanded numbers of skeletal muscle progenitor cells. The Zon Lab collaborated with Amy Wagers, PhD, of HSCI and the Joslin Diabetes Center, and C. Ronald Kahn, MD, of Joslin to conduct experiments in a mouse model of Duchenne muscular dystrophy. “One of our chemicals, forskolin, also increased engraftment of progenitors into the muscles of the mice,” Zon says. “We found you could get more muscle mass just by making more progenitors.”
(Forskolin, though not approved by the FDA, has been used since ancient times to treat a variety of disorders and is sold as a dietary supplement.)
3# Patient-specific cells
Zon, Wagers, Kahn and colleagues next turned to human cells in a dish, working with induced pluripotent stem cells (iPS cells) made from the skin cells of patients with Duchenne muscular dystrophy. “Many muscle diseases could not be adequately modeled in iPS cells in the past,” notes Zon. “No one’s been able to get iPS cells to form skeletal muscle.”
The researchers found that a combination of three small molecules (forskolin, basic fibroblast growth factor and a glycogen synthase kinase-3 GSK-3beta inhibitor) was able to reprogram iPS cells into muscle cells that successfully engrafted in mice.
Zon’s next goal is to transplant these muscle cells from the dish into patients through clinical trials he hopes develop within the next several years. He may begin by trying to increase muscle mass in a specific anatomic location, but for a condition like Duchenne muscular dystrophy, he envisions a series of local injections in different parts of the body.
Zon believes that the combination of rapid zebrafish screening with patient-specific iPS cells will greatly speed up therapeutic development, allowing scientists to quickly vet large numbers of compounds and possible culture conditions. They can then enter a much shorter list of compounds into lengthier testing in human iPS cells that recapitulate the disease in question, as well as live mouse models.
“It’s been very hard to figure out the conditions for making different tissues with iPS cells,” Zon says. “We’ve created a very fast system to find what chemicals you need. Because it’s so fast, we don’t need a hypothesis to do an experiment—you can just do the screen, find the result and see what warrants pursuing.”
The zebrafish system can also quickly spot inhibitors of tissue growth; in fact, it grew out of the lab’s desire to find chemicals that blocked muscle development to treat rhabdomyosarcoma, a tumor that grows in skeletal muscle. The Zon Lab is also using it to find chemicals that can block expansion of melanocytes, potentially halting melanoma.
Go deeper with Bing News on:
- New gene correction therapy for Duchenne muscular dystrophyon January 28, 2020 at 5:01 am
Duchenne type muscular dystrophy (DMD) is the most common hereditary muscular disease among children, leaving them wheelchair-bound before the age of 12 and reducing life expectancy. Researchers at ...
- Muscular Dystrophy Association Announces 2020-2021 National Ambassador Ethan LyBrand from Alabamaon January 28, 2020 at 5:00 am
NEW YORK, Jan. 28, 2020 /PRNewswire/ -- The Muscular Dystrophy Association (MDA) named 10-year-old Ethan LyBrand as its 2020-2021 MDA National Ambassador. Ethan and his parents, Jordan and Josh ...
- Gene scissors against incurable muscular diseaseon January 28, 2020 at 12:52 am
As a result, their existing muscle cells deteriorate over time and are gradually replaced by connective and fatty tissue; muscle strength weakens during the course of the disease. The first symptoms ...
- CRISPR gene-editing corrects muscular dystrophy in pigson January 27, 2020 at 10:59 pm
Duchenne muscular dystrophy (DMD) is one of the most common and most devastating muscular diseases, greatly reducing patients’ quality of life and life expectancy. Now, researchers in Germany have ...
- 5 Things to Know About Muscular Dystrophyon January 27, 2020 at 4:46 pm
There are thousands of genes involved in making the proteins that protect your muscles from damage. Muscular dystrophy (MD) is a group of more than thirty genetic diseases the impact these genes. In ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Human muscle cells
- 'Scrambled' cells fix themselveson January 28, 2020 at 9:45 am
Human cells have a defense mechanism that protects them from microbial attacks, a Canadian-led team of international researchers has discovered. When microbes enter our body, they liberate toxins ...
- Global Stem Cell Banking Market Analysis, Trends, and Forecasts 2019-2025 - ResearchAndMarkets.comon January 28, 2020 at 5:19 am
Benefits of stem cells include ability to reverse diseases like Parkinsons by growing new, healthy and functioning brain cells; heal and regenerate tissues and muscles damaged by heart attack ...
- Human organ chips for better drug developmenton January 27, 2020 at 4:11 pm
On one side, the channel contains cells from a specific organ. On the other side ... The computation shows what would happen if the organ was of the size that is typical of the average human body.
- Harvard Researchers Create ‘Body-On-Chips’ That May Allow Safer Drug Testingon January 27, 2020 at 12:22 pm
BOSTON (CBS) — Imagine testing new drugs on the human body, but not on people. That’s exactly what local scientists say ... the past decade developing “organs-on-chip” which are small plastic ...
- Parkinson's disease may affect brain cells before birthon January 27, 2020 at 12:15 pm
This process involves taking adult blood cells "back in time" to a primitive embryonic state. These iPSCs can then produce any cell type of the human body, all genetically identical to the patient's ...